The credit is broader than most businesses realize, and the expensing rules have changed. Some businesses may still have a fact-specific path to address forced amortization from prior years.
The R&D benefit sits across two Code sections that work together but are often confused. Understanding the distinction is the first step to claiming both.
Governs how research and experimental (R&E) costs are deducted or amortized. OBBBA permanently restored immediate expensing for domestic R&E starting in 2025. Foreign R&E still amortizes over 15 years. This is about when the cost hits taxable income.
A dollar-for-dollar tax credit for qualified research expenses (QREs). The credit directly reduces tax owed, not just taxable income. Startups can apply it against payroll taxes. This is the bigger prize per dollar.
The two are complementary. Section 174A lets you deduct the research spend immediately. Section 41 gives you a credit on top of that. You can claim both, though the deduction must be reduced by the credit amount (or you can elect a reduced credit and keep the full deduction). Most taxpayers elect the reduced credit to avoid the complexity.
To generate a credit under Section 41, a research activity must pass all four parts of the qualification test. Miss one and the activity does not count, even if it feels like research.
The research must relate to a new or improved business component: a product, process, software, technique, formula, or invention. The purpose must be functional, not aesthetic or stylistic.
The process of experimentation must rely on principles of the physical or biological sciences, engineering, or computer science. Market research, surveys, and social science do not qualify.
At the outset, there must be genuine uncertainty about the capability, method, or design. If the answer is already known in the field, it is not research.
The taxpayer must evaluate alternatives through modeling, simulation, trial and error, or systematic testing. Simply following a known specification does not count.
The credit is not limited to labs and pharmaceuticals. Any business that develops, designs, or improves products or processes through technical experimentation potentially qualifies.
The credit is computed on qualified research expenses (QREs). Four categories of spending can generate QREs, but only the portion directly tied to qualifying activities counts.
Salaries, wages, and bonuses for employees performing, supervising, or directly supporting qualified research.
Tangible property used or consumed in research. Prototypes, raw materials, testing equipment consumed in the process.
65% of amounts paid to third parties for qualified research performed on the taxpayer's behalf.
Cloud computing costs used in qualified research (post-2022), including server time for simulations and testing.
The credit is generally 20% of QREs above a base amount (the Regular Credit method) or 14% of QREs above 50% of the average QREs for the prior three years (the Alternative Simplified Credit). Most small and mid-size businesses use the ASC because it requires less historical data and is simpler to compute.
Qualified Small Businesses (under $5M gross receipts, no more than 5 tax years with gross receipts) can apply the R&D credit against payroll taxes instead of income tax. Up to $500,000 per year. This is how pre-revenue startups monetize R&D.
Elect the reduced credit (Section 280C(c)(3)) and keep your full Section 174A deduction without having to reduce it by the credit amount. Most practitioners recommend this path for its simplicity.
Three things happened at once in July 2025, and each one requires a different action.
Domestic R&E costs are fully deductible in the year incurred, permanently, starting in tax year 2025. No more five-year amortization. Foreign R&E still amortizes over 15 years. This is a permanent structural change, not a temporary provision.
Remaining unamortized domestic R&E from the forced-capitalization years can be deducted entirely in 2025 or spread over 2025-2026. This is available to all taxpayers, not just small businesses, via an accounting method change.
Eligible small businesses may be able to retroactively apply Section 174A to 2022, 2023, and 2024. This can generate refunds where forced amortization increased taxable income. Whether a claim remains available depends on the entity's facts, filing dates, and the applicable limitations period.
The R&D credit is often missed because its name makes it sound limited to biotech firms and defense contractors. It is not. A business that develops, designs, or improves a product or process through systematic experimentation may qualify. With immediate expensing restored, the practical question is whether the activity and documentation support the claim.
A short conversation is usually enough to know whether the credit applies to your business and whether a retroactive study is worth commissioning.